Showing results (141-150 of 431) with videos related to
Sort By:
Pageof 44
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1984
Comparison of the immunosuppressive effect of fractionated total lymphoid irradiation (TLI) vs conventional immunosuppression (CI) in renal cadaveric allotransplantationM Waer, Y Vanrenterghem, K K Ang, et al.Oncology Research|November 24, 1999
9-(2-phosphonylmethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine: a novel prodrug of 9-(2-phosphonylmethoxyethyl)guanine with improved antitumor efficacy and selectivity in choriocarcinoma-bearing ratsL Naesens, S Hatse, C Segers, et al.Journal Belge De Radiologie|November 1, 1990
Duplex Doppler evaluation of renal allograft dysfunction: Doppler signal quantitation and pathologic correlationH Rigauts, G Marchal, M Grieten, et al.Advances in Experimental Medicine and Biology|May 23, 1998
In vitro and in vivo inhibitory activity of the differentiation-inducing agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) against rat choriocarcinomaS Hatse, L Naesens, B Degrève, et al.Transplantation Proceedings|October 28, 2009
An easy and reproducible model of kidney transplantation in ratsT Soma, E Lerut, A Billiau, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
A single center evaluation of the Collaborative Transplant Study (CTS) DNA projectM P Emonds, Y Mytilineos, S Scherer, et al.Acta Clinica Belgica|May 14, 2014
Effectiveness and tolerability of second-line therapy with vildagliptin versus other oral agents in type 2 diabetes (EDGE): post-hoc subanalysis of the Belgian dataJ Hoste, E Daci, C MathieuActa Clinica Belgica|January 25, 2014
SGLT2-inhibitors: a novel class for the treatment of type 2 diabetes introduction of SGLT2-inhibitors in clinical practiceJ Cuypers, C Mathieu, K BenhalimaCarbohydrate Research|August 15, 1986
The use of an immobilised cyclic multi-enzyme system to synthesise branched penta- and hexa-saccharides associated with blood-group I epitopesC Augé, C Mathieu, C MérienneActa Clinica Belgica|December 16, 2004
Diabetic management in high risk patients (pregnancy, insulin pumps)G Vanhaverbeke, A Mertens, C MathieuPageof 44